Research ExplorerScientific StaffNina Booken

PD Dr. med. ID: 3170352

Nina Booken

graph of relations
Affiliations

Publications

Erfolgreiche Behandlung eines Checkpoint‐Inhibitor‐assoziierten bullösen Pemphigoids mit Dupilumab bei Angiosarkom: Successful treatment of checkpoint inhibitor‐associated bullous pemphigoid with dupilumab in a patient with angiosarcoma

Research output: SCORING: Contribution to journal › Letter › Research › peer-review

Successful treatment of checkpoint inhibitor-associated bullous pemphigoid with dupilumab in a patient with angiosarcoma

Research output: SCORING: Contribution to journal › Letter › Research › peer-review

Successful treatment of refractory checkpoint inhibitor-induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab

Research output: SCORING: Contribution to journal › Case report › Research › peer-review

Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Therapie des nekrobiotischen Xanthogranuloms - Fallserie und aktuelle Literatur:

Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

Therapy of necrobiotic xanthogranuloma - case series and review of the literature

Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

SARS-CoV-2 infection associated with severe oral, conjunctival and genital lesions (Fuchs syndrome)

Research output: SCORING: Contribution to journal › Letter › Research › peer-review

Asymptomatic erythematous plaque on the lower leg

Research output: SCORING: Contribution to journal › Case report › Education › peer-review

Successful Treatment of PD-1 Inhibitor-induced Psoriasis with Infliximab

Research output: SCORING: Contribution to journal › Letter › Research

View all (37)